SCHEMBL6710189

SCHEMBL6710189

COc1cccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(Br)cc4-c4noc(=O)[nH]4)[nH]c23)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.45
PARP14 Q460N5 1/20 0.44
MAPT P10636 4/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
BRAF P15056 1/20 0.39
CSNK1D P48730 2/20 0.38
KCNQ2 O43526 1/20 0.38
GAA P10253 1/20 0.38
ADORA2B P29275 1/20 0.38
GPR35 Q9HC97 2/20 0.38
RAB9A P51151 1/20 0.38
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708829 0.93 PARP14 (0.42) POLBPARP14MAPTTP53KMT2A
SCHEMBL6708743 0.91 POLB (0.45) POLBPARP14MAPTLMNATP53
SCHEMBL6711733 0.91 PARP14 (0.45) POLBPARP14MAPTLMNATP53
SCHEMBL6711931 0.90 L3MBTL1 (0.38) POLBMAPTKMT2AMEN1KCNQ2
SCHEMBL6710051 0.90 MEN1 (0.40) PARP14KMT2AMEN1ALDH1A1GAA
SCHEMBL6713651 0.89 MEN1 (0.44) KMT2AMEN1
SCHEMBL6709985 0.89 PARP14 (0.43) POLBPARP14MAPTLMNATP53
SCHEMBL6707815 0.89 PARP14 (0.42) POLBPARP14MAPTTP53KMT2A
SCHEMBL6709181 0.89 GRIK1 (0.44) POLBMAPTLMNAKMT2AMEN1
SCHEMBL6711425 0.88 PARP14 (0.40) PARP14MAPTKMT2AMEN1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 POLB 626/4885PARP14 2597/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.